Quinone oxidoreductases are flavoproteins that catalyze two-electron reduct
ion and detoxification of quinones. This leads to the protection of cells a
gainst toxicity, mutagenicity, and cancer due to exposure to environmental
and synthetic quinones and its precursors. Two cytosolic forms of quinone o
xidoreductases [NAD(P)H:quinone oxidoreductase 1 (NQO1) and NRH:quinone oxi
doreductase 2 (NQO2)] were previously identified, purified, and cloned. A r
ole of cytosolic NQO1 in protection of cells from oxidative stress, cytotox
icity, and mutagenicity of quinones was established. Currently, we have cha
racterized and partially purified the NQO activity from rat liver microsome
s. This activity was designated as microsomal NQO (mNQO). The mNQO activity
showed significantly higher affinity for NADH than NADPH as electron donor
s and catalyzed reduction of 2,6-dichlorophenolindophenol and menadione. Th
e mNQO activity was insensitive to dicoumarol, a potent inhibitor of cytoso
lic NQO1, Western analysis of microsomal proteins revealed 29- and 18-kDa b
ands that cross-reacted with polyclonal antibodies raised against cytosolic
NQO1. The mNQO activity was partially purified by solubilization of micros
omes with detergent Chaps, ammonium sulfate fractionation, and DEAE-Sephace
l column chromatography. The microsomal mNQO proteins are expected to provi
de additional protection after cytosolic NQOs against quinone toxicity and
mutagenicity. (C) 2000 Academic Press.